Peripheral arterial disease in diabetes: Is there a role for genetics?

Current Diabetes Reports

Volumn 11, Issue 3, 2011, Pages 218-225

  Katwal, Arabindra B ^a   Dokun, Ayotunde O ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Angiogenesis; Artherosclerosis; Diabetes; Gene association studies; Gene polymorphism; Gene environment; Genetics; Genome wide association studies; Haplotype; Hind limb ischemia; Linkage disequilibrium; Modifier gene; Peripheral arterial disease; Quantitative trait locus; Single nucleotide polymorphism; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ANGIOGENESIS; ATHEROSCLEROSIS; CLINICAL FEATURE; DIABETES MELLITUS; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

ANIMALS; DIABETES MELLITUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PERIPHERAL ARTERIAL DISEASE; POLYMORPHISM, GENETIC;

EID: 79955907244     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-011-0188-9     Document Type: Review

References (77)

1. Gerhard M, Baum P, Raby KE. Peripheral arterial-vascular disease in women: prevalence, prognosis, and treatment. Cardiology. 1995;86(4):349-55.
2. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33(1):13-8. (Pubitemid 15153432)
3. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286 (11):1317-24. (Pubitemid 33015522)
4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-S75. (Pubitemid 46068992)
5. Fowkes FG. Peripheral vascular disease: a public health perspective. J Public Health Med. 1990;12(3-4):152-9.
6. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995;91(5):1472-9.
7. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277(22):1775-81.
8. Darius H, Pittrow D, Haberl R, Trampisch HJ, Schuster A, Lange S, et al. Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients. Eur J Clin Invest. 2003;33(9):751-7. (Pubitemid 37082860)
9. Association AD. Peripheral arterial disease in people with diabetes. Clin Diabetes. 2004;22(4):181-9.
10. Keen H, Clark C, Laakso M. Reducing the burden of diabetes: managing cardiovascular disease†. Diab/Metab Res Rev. 1999;15 (3):186-96. (Pubitemid 29359036)
11. Yi-Der J, Yi-Cheng C, Yen-Feng C, Tien-Jyun C, Hung-Yuan L, Wen-Hsing L, et al. SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PADin type 2 diabetes. BMC Med Genet. 11:126-32.
12. Carmelli D, Fabsitz RR, Swan GE, Reed T, Miller B, Wolf PA. Contribution of genetic and environmental influences to anklebrachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood Institute. Am J Epidemiol. 2000;151(5):452-8. (Pubitemid 30471019)
13. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19(3):538-45.
14. Ouriel K. Peripheral arterial disease. Lancet. 2001;358(9289):1257-64. (Pubitemid 33010855)
15. Findley CM, Mitchell RG, Duscha BD, Annex BH, Kontos CD. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;52(5):387-93. (Pubitemid 352001343)
16. McDermott MM, Lloyd-Jones DM. The role of biomarkers and genetics in peripheral arterial disease. J Am Coll Cardiol. 2009;54(14):1228-37.
17. Wilson AM, Kimura E, Harada RK, Nair N, Narasimhan B, Meng X-Y, et al. {beta}2-Microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation. 2007;116(12):1396-403. (Pubitemid 47417566)
18. McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136(12):873-83. (Pubitemid 34625699)
19. Imparato AM, Kim GE, Davidson T, Crowley JG. Intermittent claudication: its natural course. Surgery. 1975;78(6):795-9.
20. Boyd AM. The natural course of arteriosclerosis of the lower extremities. Proc R Soc Med. 1962;55:591-3.
21. Cronenwett JL, Warner KG, Zelenock GB, Whitehouse Jr WM, Graham LM, Lindenauer M, et al. Intermittent claudication. Current results of nonoperative management. Arch Surg. 1984;119 (4):430-6.
22. Sheehan P. Peripheral arterial disease in people with diabetes: consensus statement recommends screening. Clin Diabetes. 2004;22(4):179-80.
23. Jude EB, Oyibo SO, Chalmers N, Boulton AJM. Peripheral arterial disease in diabetic and nondiabetic patients. Diab Care. 2001;24(8):1433-7.
24. Melton LJ, 3rd, Mackey KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diab Care. 1980;3(6):650-4. (Pubitemid 11165002)
25. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia. 1995;38(1):86-96.
26. Welborn TA, Kruiman M, McCann V, Stanton K, Constable IJ. Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables. Diabetologia. 1984;27(6):568-73. (Pubitemid 15178766)
27. Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes - a review. Diab Med. 27(1):4-14.
28. Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes - a review. Diabet Med. 2010;27(1):4-14.
29. Walters DP, Gatling WA, Mullee MA, Hill RD. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med. 1992;9(8):710-5.
30. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis. JAMA, J Am Med Assoc. 2002;287(19):2570-81.
31. Thangarajah H, Yao D, Chang EI, Shi Y, Jazayeri L, Vial IN, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proceedings of the National Academy of Sciences.
32. Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1. Circ Res. 2007;101(9):948-56. (Pubitemid 350287182)
33. Kullo IJ, Bailey KR, Kardia SL, Mosley Jr TH, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med. 2003;8(4):237-42. (Pubitemid 38585137)
34. Kullo IJ, Turner ST, Kardia SL, Mosley Jr TH, Boerwinkle E, de Andrade M. A genome-wide linkage scan for ankle-brachial index in African American and non-Hispanic white subjects participating in the GENOA study. Atherosclerosis. 2006;187(2):433-8. (Pubitemid 43963028)
35. Murabito JM, Guo CY, Fox CS, Dunknown signAgostino RB. Heritability of the ankle-brachial index: the Framingham Offspring study. Am J Epidemiol. 2006;164(10):963-8. (Pubitemid 44729837)
36. Wahlgren CM, Magnusson PKE. Genetic influences on peripheral arterial disease in a twin population. Arterioscler Thromb Vasc Biol. 31(3):678-682.
37. Dokun AO, Annex B. Genetic polymorphisms in peripheral arterial disease role of genomic methodologies. In: Ginsburg HWaG, editor. Genomic and personalized medicine. vol 1-2: Elsavier; 2008.
38. Knowles JW, Assimes TL, Li J, Quertermous T, Cooke JP. Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol. 2007;27(10):2068-78. (Pubitemid 350287233)
39. Zintzaras E, Zdoukopoulos N. A Field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: the CUMAGAS-PAD database. Am J Epidemiol. 2009;170(1):1-11. This is a recent review that provides a comprehensive overview of gene polymorphisms associated with PAD.
40. Kawashima S, Yokoyama M. Dyfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004:01.ATV.0000125114. 0000188079.0000125196.
41. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis. 2001;154(3):521-7.
42. Fatini C, Sofi F, Sticchi E, Bolli P, Sestini I, Falciani M, et al. eNOS G894T polymorphism as a mild predisposing factor for abdominal aortic aneurysm. J Vasc Surg. 2005;42(3):415-9. (Pubitemid 41323826)
43. Fatini C, Sofi F, Gensini F, Sticchi E, Lari B, Pratesi G, et al. Influence of eNOS Gene Polymorphisms on Carotid Atherosclerosis. Eur J Vasc Endovasc Surg. 2004;27(5):540-4. (Pubitemid 38529069)
44. Sticchi E, Sofi F, Romagnuolo I, Pratesi G, Pulli R, Pratesi C, et al. eNOS and ACE genes influence peripheral arterial disease predisposition in smokers. J Vasc Surg. 52(1):97-102 e101.
45. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-6. (Pubitemid 20370444)
46. Basar Y, Salmayenli N, Aksoy M, Seckin S, Aydin M, Ozkok E. ACE gene polymorphism in peripheral vascular disease. Horm Metab Res. 2007;39(7):534-7. (Pubitemid 47204200)
47. Li R, Nicklas B, Pahor M, Newman A, Sutton-Tyrrell K, Harris T, et al. Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study. J Hum Hypertens. 2007;21(8):673-82. (Pubitemid 47162730)
48. Fatini C, Sticchi E, Sofi F, Said AA, Pratesi G, Pulli R, et al. Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: role of ACE D/-240 T haplotype. J Vasc Surg. 2009;50(6):1399-404.
49. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108(19):2317-22. (Pubitemid 37413536)
50. Flex A, Gaetani E, Angelini F, Sabusco A, Chilla C, Straface G, et al. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Intern Med. 2007;262(1):124-30. (Pubitemid 47000627)
51. Libra M, Signorelli SS, Bevelacqua Y, Navolanic PM, Bevelacqua V, Polesel J, et al. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. J Clin Pathol. 2006;59(2):211-5. (Pubitemid 43235590)
52. Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res. 1998;83(6):636-43. (Pubitemid 28427747)
53. Katakami N, Sakamoto K, Kaneto H, Matsuhisa M, Shimizu I, Ishibashi F, et al. Association between the connexin37 polymorphism and peripheral arterial disease in subjects with type 2 diabetes. Diab Care. 2009;32(5):53-54. This is a short report, but it is one of only a few recent articles that identified a gene polymorphism associated with PAD among individuals with diabetes.
54. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316(5830):1491-3. (Pubitemid 46906618)
55. Cluett C, McDermott MM, Guralnik J, Ferrucci L, Bandinelli S, Miljkovic I, et al. The 9p21 myocardial infarction risk allele increases risk of peripheral artery disease in older people. Circ Cardiovasc Genet. 2009;2(4):347-53.
56. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, Manolescu A, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40(2):217-24. (Pubitemid 351171400)
57. Yee KO, Ikari Y, Schwartz SM. An update of the Grutzbalg hypothesis: the role of thrombosis and coagulation in atherosclerotic progression. Thromb Haemost. 2001;85(2):207-17.
58. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407(6801):258-64.
59. Fowkes FG, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GD. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet. 1992;339(8795):693-6.
60. Reny JL, Alhenc-Gelas M, Fontana P, Bissery A, Julia PL, Fiessinger JN, et al. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost. 2004;2(8):1334-40. (Pubitemid 40186130)
61. Conley PB, Delaney SM. Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol. 2003;10(5):333-8. (Pubitemid 36936603)
62. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost. 2001;86(1):222-32. (Pubitemid 32663953)
63. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation. 2003;108(8):989-95.
64. Fontana P, Gaussem P, Aiach M, Fiessinger JN, Emmerich J, Reny JL. P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study. Circulation. 2003;108(24):2971-3.
65. Sofi F, Lari B, Rogolino A, Marcucci R, Pratesi G, Dorigo W, et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg. 2005;41(2):255-60. (Pubitemid 40342476)
66. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-3.
67. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49(1):31-62. (Pubitemid 28197439)
68. Todesco L, Angst C, Litynski P, Loehrer F, Fowler B, Haefeli WE. Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur J Clin Invest. 1999;29(12):1003-9.
69. Sabino A, Fernandes AP, Lima LM, Ribeiro DD, Sousa MO, de Castro Santos ME, et al. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease. J Thromb Thrombolysis. 2009;27(1):82-7.
70. Pollex R, Mamakeesick M, Zinman B, Harris S, Hanley A, Hegele R. Methylenetetrahydrofolate reductase polymorphism 677 C>T is associated with peripheral arterial disease in type 2 diabetes. Cardiovasc Diabetol. 2005;4(1):17.
71. Gudmundsson G, Matthiasson SE, Arason H, Johannsson H, Runarsson F, Bjarnason H, et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am J Hum Genet. 2002;70(3):586-92. (Pubitemid 34177914)
72. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452(7187):638-642. This GWAS found an association between nicotine dependence and a SNP (rs1051730) that was also associated with PAD and lung cancer, suggesting a gene-environment interaction.
73. Jiang YD, Chang YC, Chiu YF, Chang TJ, Li HY, Lin WH, et al. SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes. BMC Med Genet. 11:126. This recent study used a candidate gene approach to identify novel gene polymorphisms associated with the risk of developing PAD among individuals with diabetes.
74. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006;38(4):452-7.
75. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615-25. (Pubitemid 40770750)
76. Dokun AO, Keum S, Hazarika S, Li Y, Lamonte GM, Wheeler F, et al. A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia. Circulation. 2008;117(9):1207-1215. This study exemplifies a novel appraoch to identifying gene polymorphisms that may be important in the pathogenesis of PAD.
77. Fukino K, Sata M, Seko Y, Hirata Y, Nagai R. Genetic background influences therapeutic effectiveness of VEGF. Biochem Biophys Res Commun. 2003;310(1):143-7. (Pubitemid 37162774)